The Business Development Bank of Canada related stories
All articles and analysis
Recently funded Pythian acquires Blackbird.ioPythian, which in March raised /canada/2014/03/05/bdc-rbc-invest-6-mln-in-data-security-specialist-pythian/ $6 million in funding, has acquired Blackbird.io, a development and data services provider with headquarters in San Francisco. The financial terms of the transaction were not released. Pythian, an Ottawa-based data management consulting and services company, said the acquisition will make it the largest open-sourced database managed services business in the world. Pythian's backers are the Business Development Bank of Canada (BDC) and Royal Bank of Canada.
- Recently funded Pythian acquires Blackbird.io
Pythian, which in March raised /canada/2014/03/05/bdc-rbc-invest-6-mln-in-data-security-specialist-pythian/ $6 million in funding, has acquired Blackbird.io, a development and data services provider with headquarters in San Francisco. The financial terms of the transaction were not released. Pythian, an Ottawa-based data management consulting and services company, said the acquisition will make it the largest open-sourced database managed services business in the world. Pythian's backers are the Business Development Bank of Canada (BDC) and Royal Bank of Canada.
BDC Venture Capital and Accel-Rx join forces to fund Canadian health science cosBDC Venture Capital and the Accel-Rx Health Sciences Accelerator are joining forces to provide seed funding to new and emerging Canadian health sciences companies. Accel-Rx, BDC Venture Capital and CDRD Ventures Inc, which will provide the initial management to launch Accel-Rx operations, will focus on maximizing new health sciences company creation.
BDC partners with Accel-Rx to seed health sciences companiesBDC Venture Capital and Accel-Rx Health Sciences Accelerator have formed a partnership to provide seed funding to Canadian health sciences startups. Accel-Rx, BDC and CDRD Ventures jointly will focus on company creation and the supply of resources needed for growth and development. The seed capital partnership with BDC will be the main funding mechanism, with selected Accel-Rx companies each receiving a $500,000 convertible note. The initial goal will be investments in up to four companies annually, with that number potentially increasing over time. Since 2012, BDC has provided $11 million in convertible notes funding to 74 information technology startups.
- BDC partners with Accel-Rx to seed health sciences companies
BDC Venture Capital and Accel-Rx Health Sciences Accelerator have formed a partnership to provide seed funding to Canadian health sciences startups. Accel-Rx, BDC and CDRD Ventures jointly will focus on company creation and the supply of resources needed for growth and development. The seed capital partnership with BDC will be the main funding mechanism, with selected Accel-Rx companies each receiving a $500,000 convertible note. The initial goal will be investments in up to four companies annually, with that number potentially increasing over time. Since 2012, BDC has provided $11 million in convertible notes funding to 74 information technology startups.
Teralys, Fonds de solidarité FTQ, BDC invest in Versant VenturesCanadian technology-focused fund-of-funds manager Teralys Capital has partnered with the Fonds de solidarité des travailleurs du Québec FTQ and BDC Venture Capital in backing U.S. life sciences venture capital firm Versant Ventures. Teralys committed $25 million to Versant, making its fifth investment in life sciences, an integral part of Teralys' and its partners' strategy to bolster the market ecosystem in Québec and across Canada. The three investor groups also plan to work with the firm on its recently launched /canada/2014/06/24/versant-ventures-brings-inception-sciences-to-montreal/ drug discovery incubator Inception Sciences, located in Montréal. Northleaf Venture Catalyst Fund also announced /canada/2014/06/24/nvcf-commits-10-mln-to-canadian-expansion-of-versant-ventures/ a $10 million commitment to Versant.
- Teralys, Fonds de solidarité FTQ, BDC invest in Versant Ventures
Canadian technology-focused fund-of-funds manager Teralys Capital has partnered with the Fonds de solidarité des travailleurs du Québec FTQ and BDC Venture Capital in backing U.S. life sciences venture capital firm Versant Ventures. Teralys committed $25 million to Versant, making its fifth investment in life sciences, an integral part of Teralys' and its partners' strategy to bolster the market ecosystem in Québec and across Canada. The three investor groups also plan to work with the firm on its recently launched /canada/2014/06/24/versant-ventures-brings-inception-sciences-to-montreal/ drug discovery incubator Inception Sciences, located in Montréal. Northleaf Venture Catalyst Fund also announced /canada/2014/06/24/nvcf-commits-10-mln-to-canadian-expansion-of-versant-ventures/ a $10 million commitment to Versant.
Angels invest $89 million in Canadian innovative companies in 2013Canadian angel groups invested a total of $89 million in early-stage companies last year. That is according to a new report http://nacocanada.com/wp-content/uploads/2014/05/2013_Report-on-Angel-Investing_Report_Web.pdf published by the National Angel Capital Organization in partnership with the Canadian government, KPMG Enterprise and BDC Venture Capital. The 29 groups that participated in the study, representing more than 2,100 individual investors, were engaged in 199 deals in 2013. Angel funds were focused on information technology sectors, which took around $29 million invested, as well as life sciences and clean technology. The report also found that startups sponsored by Canadian accelerators last year captured more than $31 million from angel investors, venture capitalists and government sources.
VC-backed software company Mirametrix wins BDC Innovation AwardThe Business Development Bank of Canada (BDC) and Canada's Venture Capital & Private Equity Association (CVCA) have announced Mirametrix Inc as the inaugural winner of the BDC Innovation Award. The award honours an early-stage Canadian company that has succeeded in bringing innovation into the marketplace in a novel and exciting way. Based in Montréal, Mirametrix is a provider of eye-tracking software and devices to aid in human and computer interaction. It is also a portfolio company of venture capital firm TandemLaunch, and was in 2013 supported by an investment /canada/2013/12/13/mirametrix-funded-by-anges-quebec-appoints-denis-lavallee-president-and-ceo/ from members of angel organization Anges Québec.
Sam Duboc wins CVCA's 2014 Ted Anderson community leadership awardCanada’s Venture Capital & Private Equity Association (CVCA) has announced that the 2014 Community Leadership Award, recently renamed the Ted Anderson Community Leadership Award, has been awarded to Sam Duboc, founder, president and managing partner of Canadian private equity firm Edgestone Capital Partners. Duboc was recognized for his many contributions to non-profits and community organizations, including his role in Pathways to Education Canada. The CVCA renamed its award in honour of Ted Anderson, former CVCA president and long-time partner at Ventures West Capital, who died last May.